切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2023, Vol. 17 ›› Issue (04) : 413 -417. doi: 10.3877/cma.j.issn.1674-3946.2023.04.017

论著

RPS21在肝细胞癌中的表达及与免疫浸润和预后的关系研究
王勇, 黄铁模, 于守君()   
  1. 264100 山东烟台,滨州医学院烟台附属医院肝胆胰脾外科
    264001 山东烟台,烟台市奇山医院普外科
    264001 山东烟台,烟台市奇山医院肝胆胰脾外科微创中心
  • 收稿日期:2023-03-07 出版日期:2023-08-26
  • 通信作者: 于守君

The expression of RPS21 in hepatocellular carcinoma and its relationship with immune invasion and prognosis

Yong Wang, Tiemo Huang, Shoujun Yu()   

  1. Department of Hepatobiliary, Pancreatic and spleen Surgery, Pancreatic and Spleen Surgery, Yantai Affiliated Hospital of Binzhou Medical College, Yantai Shandong Province 264100, China
    Department of General Surgery, Yantai Qishan Hospital, Yantai Shandong Province 264001, China
    Minimally Invasive Center of Hepatobiliary, Pancreatic and Spleen Surgery, Yantai Affiliated Hospital of Binzhou Medical College, Yantai Shandong Province 264100, China
  • Received:2023-03-07 Published:2023-08-26
  • Corresponding author: Shoujun Yu
  • Supported by:
    Tantai Science and Technology Plan Project(2022YD086)
引用本文:

王勇, 黄铁模, 于守君. RPS21在肝细胞癌中的表达及与免疫浸润和预后的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 413-417.

Yong Wang, Tiemo Huang, Shoujun Yu. The expression of RPS21 in hepatocellular carcinoma and its relationship with immune invasion and prognosis[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(04): 413-417.

目的

研究RPS21在肝细胞癌(HCC)中的表达及与免疫浸润和预后的关系。

方法

回顾性分析2018年8月至2022年12月108例HCC患者资料。通过免疫组织化学法(IHC)和逆转录定量聚合酶链反应(RT-qPCR)法检测HCC组织及相应的癌旁正常组织(距癌组织边缘>5 cm)中RPS21蛋白及mRNA的表达情况。数据应用SPSS 20.0软件处理。采用χ2检验或秩和检验分析RPS21与临床病理特征的关系,利用Kaplan-Meier生存曲线分析RPS21表达与预后的关系,采用Spearman秩相关分析RPS21与免疫浸润水平的相关性。P<0.05为差异有统计学意义。

结果

IHC及RT-qPCR结果显示,HCC组织中RPS21蛋白的阳性表达率显著高于癌旁正常组织(84.3%vs.27.8%,P<0.05),且与癌旁正常组织相比,RPS21mRNA在HCC组织中表达显著上调[(10.1±1.1)vs.(5.5±0.8),P<0.05)]。RPS21高表达与TMN分期及Edmondson分级显著相关(P<0.05)。Spearman秩相关分析显示,HCC中RPS21表达与CD4+肿瘤浸润淋巴细胞(CD4+TILs)、CD8+肿瘤浸润淋巴细胞(CD8+TILs)、Foxp3+调节性T淋巴细胞(Foxp3+Trges)、CD11c+树突状细胞(CD11c+DCs)及CD163+肿瘤相关巨噬细胞(CD163+TAMs)的浸润数目呈正相关(P<0.05)。中位随访时间33个月,通过Kaplan-Meier分析显示,RPS21高表达组的患者累积总生存率及累积无病生存率显著低于RPS21低表达组(65.4%vs.81.5%,61.7%vs.77.8%),差异均有统计学意义(P=0.041、0.044)。

结论

RPS21在HCC组织中呈高表达,且RPS21高表达与HCC的TMN分期、Edmondson分级、免疫浸润及预后密切相关。RPS21可能参与了HCC的发生和发展,同时也可能参免疫调节。

Objective

To study the expression of RPS21 in hepatocellular carcinoma(HCC)and its relationship with immune invasion and prognosis.

Methods

A total of 108 HCC patients from August 2018 to December 2022 were retrospectively included as study subjects. Immunohistochemistry(IHC)and reverse transcriptional quantitative polymerase chain reaction(RT-qPCR)were used to detect the expression of RPS21 protein and mRNA in HCC tissues and corresponding paracancer tissues(>5 cm from the margin of cancer tissue). The data was processed by SPSS 20.0 software. χ2 test or Rank Sum test were used to analyze the relationship between RPS21 and clinicopathologic features,Kaplan-Meier survival curve was used to analyze the relationship between RPS21 expression and prognosis,and Spearman Rank correlation was used to analyze the correlation between RPS21 expression and immune infiltration level. P<0.05 was considered statistically significant.

Results

IHC and RT-qPCR results showed that the positive expression rate of RPS21 protein in HCC tissues was significantly higher than that in paracancer normal tissues(84.3%vs.27.8%,P<0.05),and compared with paracancer normal tissues,The expression of RPS21mRNA was significantly up-regulated in HCC tissues[(10.1±1.1)vs.(5.5±0.8),P<0.05]. The high expression of RPS21 was significantly correlated with TMN stage and Edmondson grade(P<0.05). Spearman rank correlation analysis showed that Expression of RPS21 in HCC is associated with tumor macrotropia in CD4+ tumor infiltrating lymphocytes(CD4+TILs),CD8+TILs,Foxp3+ regulatory T lymphocytes(Foxp3+Trges),CD11c+ dendritic cells(CD11c+DCs),and CD163+ The infiltration number of macrophages(CD163+TAMs)was positively correlated(P<0.05). After a median follow-up of 33 months,Kaplan-Meier analysis showed that the cumulative overall survival rate and disease-free survival rate of the high RPS21 expression group were significantly lower than those of the low RPS21 expression group(65.4%vs.81.5%,61.7%vs.77.8%). The differences were statistically significant(P=0.041,0.044).

Conclusion

RPS21 is highly expressed in HCC tissues,and the high expression of RPS21 is closely related to TMN stage,Edmondson grade,immune invasion and prognosis of HCC. RPS21 may be involved in the occurrence and development of HCC,and may also be involved in immune regulation.

表1 108例HCC患者病理特征
图1 108例HCC组织及癌旁正常组织标本中RPS21蛋白和mRNA的表达情况
表2 108例HCC患者中RPS21表达与临床病理特征的关系[(
x¯
±s),例]
图2 108例HCC患者中CD4+TILs、CD8+TILs、Foxp3+Trges、CD11c+DCs及CD163+TAMs的表达情况
表3 108例HCC患者中RPS21表达与免疫浸润的关系
图3 108例HCC患者中RPS21表达与预后的生存曲线
[1]
沈锋,邹奇飞,范明明,等. 中国腹腔镜肝癌切除术20年发展、问题与对策[J/CD]. 中华普外科手术学杂志(电子版)202115(04):369-373.
[2]
Dinh TTHIseki HMizuno S,et al. Disruption of entire Cables2 locus leads to embryonic lethality by diminished Rps21 gene expression and enhanced p53 pathway[J]. Elife202110:e50346.
[3]
Liang ZMou QPan Z,et al. Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer:RPL22L1 and RPS21[J]. Med Oncol201936(6):56.
[4]
Wang TWang ZYZeng LY,et al. Down-Regulation of Ribosomal Protein RPS21 Inhibits Invasive Behavior of Osteosarcoma Cells Through the Inactivation of MAPK Pathway[J]. Cancer Manag Res202012:4949-4955.
[5]
Deng YZhao HYe L,et al. Correlations Between the Characteristics of Alternative Splicing Events,Prognosis,and the Immune Microenvironment in Breast Cancer[J]. Front Genet202112:686298.
[6]
施婷婷,刘振球,樊虹,等. 2005-2016年中国肝癌发病趋势分析[J]. 中华流行病学杂志202243(03):330-335.
[7]
何凤蝶,王秋童,胡亚男,等. 中国人群肝癌发病危险因素病例对照研究的meta分析[J]. 现代预防医学202249(23):4230-4240.
[8]
Ren ZMa XDuan Z,et al. Diagnosis,Therapy,and Prognosis for Hepatocellular Carcinoma[J]. Anal Cell Pathol(Amst)20202020:8157406.
[9]
叶于富,陈伟,白雪莉. 中国腹腔镜肝癌手术20年演变历程与成就[J/CD]. 中华普外科手术学杂志(电子版)202115(04):363-368.
[10]
袁飞,王树斌. 核糖体蛋白与恶性肿瘤治疗研究进展[J/CD]. 肿瘤代谢与营养电子杂志20196(01):116-119.
[11]
Garcia EL. Allele-specific alternative splicing of Drosophila Ribosomal protein S21 suppresses a lethal mutation in the Phosphorylated adaptor for RNA export(Phax)gene[J]. G3(Bethesda)202212(9):jkac195.
[12]
Sawyer JKKabiri ZMontague RA,et al. Exploiting codon usage identifies intensity-specific modifiers of Ras/MAPK signaling in vivo[J]. PLoS Genet202016(12):e1009228.
[13]
Xu YWei ZFeng M,et al. Tumor-infiltrated activated B cells suppress liver metastasis of colorectal cancers[J]. Cell Rep202240(9):111295.
[1] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[2] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[3] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[4] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[5] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[6] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[7] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[8] 鲁鑫, 许佳怡, 刘洋, 杨琴, 鞠雯雯, 徐缨龙. 早期LC术与PTCD续贯LC术治疗急性胆囊炎对患者肝功能及预后的影响比较[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 648-650.
[9] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[10] 钟广俊, 刘春华, 朱万森, 徐晓雷, 王兆军. MRI联合不同扫描序列在胃癌术前分期诊断及化疗效果和预后的评估[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 378-382.
[11] 胡宝茹, 尚乃舰, 高迪. 中晚期肝细胞癌的DCE-MRI及DWI表现与免疫治疗预后的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 399-403.
[12] 陆萍, 邹健. 凝血和纤维蛋白溶解标志物的动态变化对急性胰腺炎患者预后的评估价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 427-432.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要